Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
about
Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.IL-17A in human respiratory diseases: innate or adaptive immunity? Clinical implications.Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge.Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology.
P2860
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@en
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@nl
type
label
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@en
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@nl
prefLabel
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@en
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
@nl
P2093
P50
P921
P1476
Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells
@en
P2093
Annick Clement
Carine Rebeyrol
Jacky Jacquot
P356
10.1016/J.EJPHAR.2011.10.027
P407
P577
2011-10-26T00:00:00Z